EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 7.065

 ICV - 79.57

Abstract

SELECTION OF OPTIMAL PARAMETERS AND REVISITING FUNCTIONAL CHARACTERIZATION OF CXCR1 IN RESPONSE TO STAPHYLOCOCCUS AUREUS INFECTION

Puja Dutta and Biswadev Bishayi*

ABSTRACT

Staphylococcus aureus, a major opportunistic pathogen, can cause spacious range of infections in animals and humans. Treatment of S.aureus induced sepsis and inflammatory diseases have become the need of the hour. S.aureus stimulated murine peritoneal macrophages releasesa major chemokine, CXCL8 and aggravate CXCR1 expression on the macrophage surface. CXCL8/CXCR1 axis is pivotal for leucocyte recruitment and bacterial clearance from the site of infection. Extrapolating our previous research works, the effect of gradedbacterial inoculum size and peritoneal macrophage cell count on CXCL8, ROS generation, and CXCR1 expression had been evaluated. Secondly, based on the optimum doses obtained, kinetic-dependent S.aureus infection on CXCR1 expression, its subsequent effect on bacterial phagocytic phenomenon had also been studied. The bacterial inoculums size and macrophage quantity had a regulatory effect on CXCR1 expression on the macrophage surface. Increasing bacterial inoculum or macrophage quantity in the culture medium does not elevate CXCR1 expression on macrophage surface beyond a certain point, suggesting a reconcilable interaction between bacterial components and macrophage essential for receptor expression. According to the results obtained, maximum intracellular phagocytosis occurred at 60 minutes post infection. The magnitude of phagocytic activity wasfound roughly proportional to the surface CXCR1 expression on macrophage surface. Hence CXCL8/CXCR1 axis has a significant role in intracellular bacterial phagocytosis and serves as a potential therapeutic target to control S.aureus infection.

Keywords: CXCL8; CXCR1; peritoneal macrophage; phagocytosis; Staphylococcus aureus.


[Full Text Article] [Download Certificate]

Citation

  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 October 2024 Issue has been Published, Kindly check it on https://www.ejpmr.com/issue

  • EJPMR: OCTOBER ISSUE PUBLISHED

    OCTOBER 2024 issue has been successfully launched on OCTOBER 2024.

  • EJPMR New Impact Factor

    EJPMR Impact Factor has been Increased to 7.065 for Year 2024.

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along witcertificate to promote resear activity of scholar.

Best Article of current issue :

Dr. Kartik Neog
Download Article : Click here